TrialPanorama/TrialPanorama-database huggingface dataset:
Study 15907404 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 6290435 — Surrogate Endpoint (SUR): Blood pressure
Study 28874171 — Safety Biomarker (SAF): Interleukin 12
Study 28870680 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 27760998 — Surrogate Endpoint (SUR): Blood pressure
Study 25645166 — Surrogate Endpoint (SUR): Blood pressure
Study 24018253 — Surrogate Endpoint (SUR): Bone mineral density
Study 20142183 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study 18181335 — Surrogate Endpoint (SUR): Blood pressure
Study 15152270 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study 15152270 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 8096703 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31704024 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 26327768 — Surrogate Endpoint (SUR): Blood pressure
Study 8114181 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 3384469 — Surrogate Endpoint (SUR): Blood pressure
Study 28225205 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 28225205 — Surrogate Endpoint (SUR): Blood pressure
Study 22136481 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 22136481 — Surrogate Endpoint (SUR): Bone mineral density
Study 12755456 — Surrogate Endpoint (SUR): Blood pressure
Study 25818798 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 23509040 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 8087820 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 23740686 — Safety Biomarker (SAF): MTHFR
Study 16884565 — Surrogate Endpoint (SUR): Blood pressure
Study 16884565 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study 16884565 — Surrogate Endpoint (SUR): Serum triglycerides
Study 10984368 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 25351016 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 18307772 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 18307772 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 18307772 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 15756254 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 12742466 — Surrogate Endpoint (SUR): Serum creatinine
Study 10868702 — Pharmacodynamic Biomarker (PDY): Homovanillic acid
Study 8239913 — Predictive Biomarker (PRD): ZFP36 mRNA
Genes: ZFP36; G0S24; NUP475; RNF162A; TIS11A; TTP
Study 3104124 — Surrogate Endpoint (SUR): Blood pressure
Study 18332071 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 10066655 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 19027977 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 19027977 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 11975864 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 7852113 — Predictive Biomarker (PRD): CR1 mRNA
Genes: CR1; C3BR
Study 7852113 — Safety Biomarker (SAF): Human leucocyte antigen
Study 23706168 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 21324992 — Surrogate Endpoint (SUR): Blood pressure
Study 15196107 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 15196107 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 16227143 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 9813556 — Surrogate Endpoint (SUR): Blood pressure
Study 30503218 — Predictive Biomarker (PRD): PRKRA mRNA
Genes: PRKRA; PACT; RAX; HSD-14; HSD14
Study 28916164 — Predictive Biomarker (PRD): NNT mRNA
Genes: NNT
Study 28002035 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 28002035 — Surrogate Endpoint (SUR): Serum creatinine
Study 23297557 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 16255878 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 7876509 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 4730188 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 28611374 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 25862299 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 25862299 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 19101235 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 17544419 — Surrogate Endpoint (SUR): Sperm parameters
Study 16943538 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 16943538 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 1286488 — Surrogate Endpoint (SUR): Blood pressure
Study 1286488 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 29873953 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 22858403 — Surrogate Endpoint (SUR): Bone mineral density
Study 21134044 — Safety Biomarker (SAF): Hyaluronic acid
Study 12368933 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 19728183 — Surrogate Endpoint (SUR): Blood pressure
Study 28591675 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 21654268 — Surrogate Endpoint (SUR): Serum uric acid
Study 16357094 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 16357094 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 9412311 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 8487666 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 8487666 — Surrogate Endpoint (SUR): Serum testosterone
Study 31928490 — Predictive Biomarker (PRD): IGDCC4 mRNA
Genes: IGDCC4; DDM36; KIAA1628; NOPE
Study 31928490 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 27521557 — Surrogate Endpoint (SUR): Serum creatinine
Study 24569129 — Surrogate Endpoint (SUR): Serum potassium
Study 18427133 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 18427133 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 18427133 — Surrogate Endpoint (SUR): Blood pressure
Study 18427133 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 2612166 — Predictive Biomarker (PRD): ELK3 mRNA
Genes: ELK3; NET; SAP2
Study 26961928 — Predictive Biomarker (PRD): RAD51 mRNA
Genes: RAD51; RAD51A; RECA
Study 26961928 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 17401796 — Surrogate Endpoint (SUR): Blood pressure
Study 17401796 — Surrogate Endpoint (SUR): Forced vital capacity
Study 7600477 — Safety Biomarker (SAF): Aminopeptidase N
Genes: ANPEP; APN; CD13; PEPN
Study 28620678 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 28620678 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study 28620678 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 12003685 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 26073397 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 26073397 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 3297895 — Predictive Biomarker (PRD): DAP mRNA
Genes: DAP; DAP1
Study 31846016 — Surrogate Endpoint (SUR): Blood pressure
Study 31846016 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 15086924 — Surrogate Endpoint (SUR): Serum creatinine
Study 15086924 — Surrogate Endpoint (SUR): Urinary oxalate
Study 12173297 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 9391220 — Predictive Biomarker (PRD): DST mRNA
Genes: DST; BP230; BP240; BPAG1; DMH; DT; KIAA0728
Study 7502689 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 354046 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 17709712 — Surrogate Endpoint (SUR): Blood pressure
Study 11477812 — Predictive Biomarker (PRD): MFSD11 mRNA
Genes: MFSD11; ET
Study 29858659 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 29858659 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 29858659 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 29454656 — Surrogate Endpoint (SUR): Blood pressure
Study 26892922 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study 17981377 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 28222072 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 26130251 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 24277402 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 12752349 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study 8213584 — Surrogate Endpoint (SUR): Blood pressure
Study 22261206 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 15849292 — Surrogate Endpoint (SUR): Bone mineral density
Study 7563511 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 15452023 — Surrogate Endpoint (SUR): Blood pressure
Study 11385189 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 26484951 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 21050239 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 21050239 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 21050239 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 2643969 — Surrogate Endpoint (SUR): Blood pressure
Study 28817301 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21105759 — Surrogate Endpoint (SUR): Blood pressure
Study 1279292 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 1279292 — Surrogate Endpoint (SUR): Blood pressure
Study 24670612 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 10703459 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 10703459 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 10703459 — Predictive Biomarker (PRD): GNL3 mRNA
Genes: GNL3; E2IG3; NS
Study 2580155 — Surrogate Endpoint (SUR): Blood pressure
Study 20955499 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24533507 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study 24533507 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 17972591 — Safety Biomarker (SAF): MMP-1
Genes: MMP1
Study 21489346 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study 25277169 — Surrogate Endpoint (SUR): Blood pressure
Study 23722592 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 26881019 — Surrogate Endpoint (SUR): Blood pressure
Study 22157800 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MHC class I polypeptide-related sequence A
Genes: MICA; PERB11.1
Study 31764289 — Safety Biomarker (SAF): Interleukin 1
Study 31764289 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 31560137 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 28599199 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 28599199 — Surrogate Endpoint (SUR): Blood pressure
Study 16923091 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 16923091 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16923091 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 16923091 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 16923091 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 27830923 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 26060880 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study 18163056 — Predictive Biomarker (PRD): LPO mRNA
Genes: LPO; SAPX
Study 9808685 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 7851350 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 7851350 — Surrogate Endpoint (SUR): Blood pressure
Study 30209161 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 30209161 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 30209161 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 28406132 — Predictive Biomarker (PRD): NNT mRNA
Genes: NNT
Study 24797300 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 9156928 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 9156928 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 1928686 — Surrogate Endpoint (SUR): Blood pressure
Study 30932955 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30932955 — Predictive Biomarker (PRD): TLR9
Genes: CD289
Study 23138399 — Surrogate Endpoint (SUR): Blood pressure
Study 19637474 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study 19637474 — Predictive Biomarker (PRD): NBPF3 mRNA
Genes: NBPF3; L7
Study 10692000 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 10692000 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 10692000 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 2865719 — Surrogate Endpoint (SUR): Blood pressure
Study 22522549 — Predictive Biomarker (PRD): EDNRA mRNA
Genes: EDNRA; ETA; ETRA
Study 22522549 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 31157963 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 31157963 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 18685525 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study 12612223 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 10805052 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 10805052 — Surrogate Endpoint (SUR): Blood pressure
Study 6441624 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 31754080 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Nuclear factor erythroid 2-related factor 2
Genes: NFE2L2; NRF2
Study 24308676 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 12660500 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 10589950 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL
Study 26649651 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 6337697 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 29045520 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 25271811 — Surrogate Endpoint (SUR): Blood pressure
Study 19332202 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study 11424169 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 24622415 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 22107691 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 22107691 — Surrogate Endpoint (SUR): Bone mineral density
Study 10632645 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study 9505989 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 9505989 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study 10367596 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 30630805 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 23684755 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23684755 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 17348758 — Surrogate Endpoint (SUR): Blood pressure
Study 23170931 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 21950641 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study 16723306 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 16723306 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 16723306 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 8173698 — Surrogate Endpoint (SUR): Blood pressure
Study 27101669 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 3319349 — Surrogate Endpoint (SUR): Serum sodium
Study 29234943 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 2869952 — Surrogate Endpoint (SUR): Blood pressure
Study 12969694 — Surrogate Endpoint (SUR): Bone mineral density
Study 8542129 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 24518158 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24518158 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 26606435 — Safety Biomarker (SAF): Hyaluronic acid
Study 7733474 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 2645503 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 28045314 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 23663810 — Surrogate Endpoint (SUR): Serum creatinine
Study 18362870 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 14666441 — Safety Biomarker (SAF): Alpha-glutathione S-transferase
Study 21870975 — Predictive Biomarker (PRD): TKT mRNA
Genes: TKT
Study 9395279 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 9395279 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 3662274 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 3662274 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 31848609 — Surrogate Endpoint (SUR): Blood pressure
Study 23479319 — Safety Biomarker (SAF): Reactive oxygen species
Study 23479319 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 20368052 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 10778867 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 2871784 — Surrogate Endpoint (SUR): Blood pressure
Study 18074229 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 16478760 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 15451891 — Surrogate Endpoint (SUR): Blood pressure
Study 8995739 — Surrogate Endpoint (SUR): Blood pressure
Study 8995739 — Surrogate Endpoint (SUR): Serum creatinine
Study 15077009 — Predictive Biomarker (PRD): DRD2 mRNA
Genes: DRD2
Study 15077009 — Predictive Biomarker (PRD): DBH mRNA
Genes: DBH
Study 15077009 — Safety Biomarker (SAF): DRD2
Study 7923668 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 2499700 — Predictive Biomarker (PRD): DPT mRNA
Genes: DPT
Study 30890102 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 19508157 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19508157 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 29627897 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study 29627897 — Predictive Biomarker (PRD): SLC22A2 mRNA
Genes: SLC22A2; OCT2
Study 29627897 — Predictive Biomarker (PRD): SLCO1A2 mRNA
Genes: SLCO1A2; OATP; OATP1; OATP1A2; SLC21A3
Study 29627897 — Predictive Biomarker (PRD): POU2F1 mRNA
Genes: POU2F1; OCT1; OTF1
Study 29627897 — Predictive Biomarker (PRD): SLC47A2 mRNA
Genes: SLC47A2; MATE2
Study 29627897 — Predictive Biomarker (PRD): SLCO1B3 mRNA
Genes: SLCO1B3; LST2; OATP1B3; OATP8; SLC21A8
Study 26761585 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 26761585 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 24659610 — Surrogate Endpoint (SUR): Blood pressure
Study 29446069 — Predictive Biomarker (PRD): IGSF6 mRNA
Genes: IGSF6; DORA
Study 27777279 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 27777279 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 2265308 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 2265308 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 11741551 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 3358882 — Surrogate Endpoint (SUR): Blood pressure
Study 20124183 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 8450517 — Surrogate Endpoint (SUR): Blood pressure
Study 2429687 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 31740103 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study 31267659 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 26290106 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 20599004 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 20599004 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 9186283 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 9186283 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 3706388 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 3706388 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 30460454 — Predictive Biomarker (PRD): MTTP mRNA
Genes: MTTP; MTP
Study 30361406 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21193295 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21193295 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26581899 — Predictive Biomarker (PRD): C1QL1 mRNA
Genes: C1QL1; C1QRF; CRF; CTRP14
Study 30528315 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 30528315 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO